Minerva Surgical(OTC) UTRS

Market Cap$900.00

Since IPO (2021)-100%

5 YearN/A

1 Year+900%

1 Month+9,900%

$0.00

+0.00%

+0.00Today

Minerva Surgical last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-19

Minerva Surgical stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-08-11
1 month	+9,900%	USD 0.00	2026-07-06
3 month	+9,900%	USD 0.00	2026-05-20
Year to date	+0%	USD 0.00	2025-12-31
1 year	+900%	USD 0.00	2025-08-14
3 year	-100%	USD 4.27	2023-08-18
Since inception	-100%	USD 180.00	2021-10-22

Minerva Surgical Financials at a Glance

Market Cap

$900.00

Revenue (TTM)

$51.69M

Net Income (TTM)

-$35.55M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.00

Volume

204

Open

$0.00

Price

$0.00

Volume

204

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 20, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.00

Volume

204

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 20, 2026

UTRS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Minerva Surgical

Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing innovative, minimally invasive solutions for women's uterine healthcare needs. The company offers a range of advanced products designed to improve patient outcomes and enhance the efficiency of healthcare providers.

Products and Services

Minerva ES and Genesys HTA endometrial ablation systems
Symphion Tissue Removal System for uterine tissue removal
Resectr Tissue Resection Device for hysteroscopic procedures

Growth Outlook

Revenue of $11.97 million in Q3 2023, showing consistent demand
Gross profit margin of 52% in Q3 2023, indicating strong product performance
Continued investment in R&D to drive future product innovations

Financial Highlights

Net income of -$7.18 million in Q3 2023, reflecting ongoing operational challenges
Cash and cash equivalents of $11.43 million as of September 30, 2023
Current ratio of 2.53, indicating strong short-term financial health

Minerva Surgical, Inc. operates in the healthcare sector, specifically within medical technology, and is headquartered in Santa Clara, California. The company was founded in 2008 and has since developed a suite of products that cater to the needs of obstetrician-gynecologists in various clinical settings. Despite facing financial challenges, including negative net income, the company maintains a solid cash position and a favorable current ratio, which suggests it can meet its short-term obligations. The focus on research and development aims to enhance product offerings and drive future growth, positioning Minerva Surgical as a key player in the women's healthcare market.

AI Generated • Aug 5, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

174

CEO

David M. Clapper

Website

minervasurgical.com

Headquarters

Santa Clara, CA 95054, US

UTRS Financials

Key Financial Metrics (TTM)

Gross Margin

54.17%

Operating Margin

-61.44%

Net Income Margin

-67.83%

Return on Equity

-111.32%

Return on Capital

-54.33%

Return on Assets

-49.51%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$900.00

Shares Outstanding

8.88M

Volume

204

Avg. Volume

22.191

Financials (TTM)

Gross Profit

$28.01M

Operating Income

-$29.26M

EBITDA

-$22.79M

Operating Cash Flow

-$38.73M

Capital Expenditure

-$69.00K

Free Cash Flow

-$38.80M

Cash & ST Invst.

$11.13M

Total Debt

$43.55M

Minerva Surgical Performance Analysis

Minerva Surgical annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 52,103,000	N/A
2022	2022-12-31	USD 50,294,000	-3.5%

Minerva Surgical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-12-31	9.7%
Q1	2023-03-31	-9.2%
Q2	2023-06-30	6.8%
Q3	2023-09-30	-10.6%

Minerva Surgical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD -14.89	N/A
2022	2022-12-31	USD -23.68	59.0%

Minerva Surgical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-12-31	74.6%
Q1	2023-03-31	-39.8%
Q2	2023-06-30	65.1%
Q3	2023-09-30	17.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

$11.97M

-4.9%

Gross Profit

$6.22M

-8.7%

Gross Margin

51.97%

N/A

Market Cap

$900.00

N/A

Market Cap/Employee

$5.17

N/A

Employees

174

N/A

Net Income

-$7.18M

+36.6%

EBITDA

-$4.56M

+41.4%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Total Cash

$11.13M

-26.4%

Total Debt

$43.55M

+9.3%

Accounts Receivable

$7.57M

+11.5%

Inventory

$18.18M

+6.9%

Long Term Debt

$31.28M

-20.4%

Short Term Debt

$12.27M

+2072.0%

Return on Assets

-49.51%

N/A

Return on Invested Capital

-56.57%

N/A

Free Cash Flow

-$5.11M

+24.9%

Operating Cash Flow

-$5.10M

+25.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ETAOFEtao International Co., Ltd.

ETAOFEtao International Co., Ltd.$0.00+0.00%

AKANAkanda Corp.

AKANAkanda Corp.$3.90-3.94%

FOXOFOXO Technologies Inc.

FOXOFOXO Technologies Inc.$0.07-30.00%

DRMADermata Therapeutics, Inc.

DRMADermata Therapeutics, Inc.$1.38-6.12%

ACONAclarion, Inc.

ACONAclarion, Inc.$2.69-2.89%

RNAZTransCode Therapeutics, Inc.

RNAZTransCode Therapeutics, Inc.$2.97-7.48%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$9.81+0.06%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$134.00-0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.88-0.03%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$41.20+0.06%

MRNAModerna

MRNAModerna$133.32-0.24%

NVDANvidia

NVDANvidia$216.85-0.00%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$17.55+0.11%

Questions About UTRS

What is the current price of Minerva Surgical?

Minerva Surgical is trading at $0.00 per share.

What is the 52-week range for Minerva Surgical?

Over the past 52 weeks, Minerva Surgical has traded between $0.00 and $0.00.

How much debt does Minerva Surgical have?

As of the most recent reporting period, Minerva Surgical reported total debt of $39.69M.

How much cash does Minerva Surgical have on hand?

Minerva Surgical reported $7.55M in cash and cash equivalents in its most recent financial results.

What is Minerva Surgical’s dividend yield?

Minerva Surgical does not currently have a dividend yield.

Minerva Surgical(OTC) UTRS

Minerva Surgical Financials at a Glance

UTRS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Minerva Surgical

UTRS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Minerva Surgical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About UTRS

What is the current price of Minerva Surgical?

What is the 52-week range for Minerva Surgical?

How much debt does Minerva Surgical have?

How much cash does Minerva Surgical have on hand?

What is Minerva Surgical’s dividend yield?

Premium Investing Services